US Company Gets Approval To Build The World's First Fusion Power Plant In Washington

Domestic Flights To Resume In Iran Tuesday, Even As Ceasefire's End Looms Large The two-week Iran ceasefire ends Wednesday, and President Trump is saying he doesn't plan to extend it if a second round of talks in Pakistan fail. These Islamabad talks, it should be noted, have not so much as even gotten off the ground. President Trump has further said "lots of bombs" will fall if there is no deal, and if Iran doesn't hand over its nuclear material. And yet the Iranians are remaining defiant and proving their resiliency...

Lilly Slides After New Obesity Pill Prescription Data Disappoints Wall Street Shares of Eli Lilly & Co. fell in New York premarket trading after new industry prescription data for the drugmaker's blockbuster obesity shot Zepbound and recently approved oral weight-loss pill Foundayo disappointed Wall Street analysts. Foundayo generated 3,707 prescriptions in its second week, according to new prescription-tracking data from IQVIA cited by RBC Capital Markets analysts. That compares with 18,410 prescriptions for Novo's oral version of Wegovy during its second week after launch, suggesting Lilly's weight-loss drugs are falling behind...

Meanwhile, the administration has stopped claiming regime change is a reason for the war. But instead claims Iranian missiles, which can't reach the USA, are the "threat."